科前生物
(688526)
| 流通市值：57.66亿 | | | 总市值：57.66亿 |
| 流通股本：4.66亿 | | | 总股本：4.66亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 169,958,032.77 | 198,571,124.68 | 176,801,385.46 | 276,965,139.5 |
| 交易性金融资产 | 1,677,403,501.13 | 1,681,145,140.52 | 1,542,274,717.04 | 922,802,114.64 |
| 应收票据及应收账款 | 276,177,743.26 | 319,631,944.54 | 285,153,391.74 | 293,500,028.16 |
| 应收账款 | 276,177,743.26 | 319,631,944.54 | 285,153,391.74 | 293,500,028.16 |
| 应收款项融资 | 11,504,729.22 | 12,807,037.11 | 17,442,021.14 | 29,210,692.42 |
| 预付款项 | 3,494,522.79 | 9,989,950.53 | 10,664,508.73 | 7,602,367.91 |
| 其他应收款合计 | 4,515,715.24 | 3,930,216.31 | 4,319,891.08 | 4,546,242.42 |
| 存货 | 146,129,164.31 | 136,299,436.08 | 144,270,957.77 | 135,650,950.37 |
| 一年内到期的非流动资产 | 726,211,599.88 | 716,688,295.66 | 664,392,235.17 | 431,082,907.9 |
| 其他流动资产 | 10,870,753.49 | 30,938,958.91 | 81,756,101.32 | 521,688,120.28 |
| 流动资产合计 | 3,026,265,762.09 | 3,110,002,104.34 | 2,927,075,209.45 | 2,623,048,563.6 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 37,231,810.4 | 56,683,858.05 | 62,077,805.2 | 67,366,667.59 |
| 固定资产 | 771,435,944.64 | 799,372,874.16 | 827,581,883.75 | 664,248,646.04 |
| 在建工程 | 36,317,989.61 | 33,552,669.03 | 33,495,000 | 221,154,992.54 |
| 生产性生物资产 | 7,685,414.2 | 9,628,155.87 | 10,560,273.6 | 14,927,538.6 |
| 使用权资产 | 6,814,705.14 | 6,910,895.35 | 6,309,051.18 | 6,340,607.42 |
| 无形资产 | 63,647,578.36 | 64,649,740.55 | 65,711,902.74 | 65,467,740.3 |
| 长期待摊费用 | 894,549.65 | 994,736.36 | 1,115,923.07 | 1,237,109.78 |
| 递延所得税资产 | 376,907.06 | 490,156 | 501,251.2 | 594,093.63 |
| 其他非流动资产 | 562,532,559.74 | 742,289,020.72 | 854,776,983.07 | 1,088,641,502.53 |
| 非流动资产合计 | 1,486,937,458.8 | 1,714,572,106.09 | 1,862,130,073.81 | 2,129,978,898.43 |
| 资产总计 | 4,513,203,220.89 | 4,824,574,210.43 | 4,789,205,283.26 | 4,753,027,462.03 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 117,234,070.63 | 110,865,218.44 | 111,322,477.39 | 131,134,059.05 |
| 其中：应付票据 | 17,463,170.26 | - | - | 104,000 |
| 应付账款 | 99,770,900.37 | 110,865,218.44 | 111,322,477.39 | 131,030,059.05 |
| 合同负债 | 161,086,979.08 | 191,753,506.88 | 182,373,777.97 | 213,701,682.84 |
| 应付职工薪酬 | 31,058,236.87 | 20,821,422.98 | 48,644,666.13 | 44,055,507.5 |
| 应交税费 | 19,258,900.25 | 33,753,702.52 | 51,018,776.79 | 43,774,158.31 |
| 其他应付款合计 | 50,632,003.6 | 51,574,200.95 | 61,410,638.51 | 58,991,034.05 |
| 一年内到期的非流动负债 | 1,759,172.51 | 965,098.76 | 1,606,893.22 | 1,461,376.38 |
| 其他流动负债 | 5,861,718.09 | 9,433,168.61 | 1,119,159.02 | 1,994,066.1 |
| 流动负债合计 | 386,891,081.03 | 419,166,319.14 | 457,496,389.03 | 495,111,884.23 |
| 非流动负债: | | | | |
| 租赁负债 | 4,827,961.2 | 5,371,349.57 | 5,073,377.15 | 5,479,637.96 |
| 递延收益 | 67,815,314.64 | 64,566,317.27 | 69,663,604.76 | 61,007,323.51 |
| 递延所得税负债 | 22,555,573.31 | 23,060,555.71 | 17,793,587.13 | 18,612,614.31 |
| 非流动负债合计 | 95,198,849.15 | 92,998,222.55 | 92,530,569.04 | 85,099,575.78 |
| 负债合计 | 482,089,930.18 | 512,164,541.69 | 550,026,958.07 | 580,211,460.01 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 466,128,056 | 466,128,056 | 466,128,056 | 466,128,056 |
| 资本公积 | 1,129,999,902.18 | 1,128,334,573.91 | 1,126,687,546 | 1,128,277,405.46 |
| 减:库存股 | 17,692,584 | 17,692,584 | 17,692,584 | 17,692,584 |
| 其他综合收益 | -3,420,253.74 | 17,254,191.7 | 24,359,003.74 | 30,532,323.21 |
| 盈余公积 | 269,372,446.08 | 269,372,446.08 | 269,372,446.08 | 269,372,446.08 |
| 未分配利润 | 2,187,327,664.19 | 2,449,162,566.2 | 2,369,926,402.39 | 2,295,331,849.71 |
| 归属于母公司股东权益合计 | 4,031,715,230.71 | 4,312,559,249.89 | 4,238,780,870.21 | 4,171,949,496.46 |
| 少数股东权益 | -601,940 | -149,581.15 | 397,454.98 | 866,505.56 |
| 股东权益合计 | 4,031,113,290.71 | 4,312,409,668.74 | 4,239,178,325.19 | 4,172,816,002.02 |
| 负债和股东权益合计 | 4,513,203,220.89 | 4,824,574,210.43 | 4,789,205,283.26 | 4,753,027,462.03 |
| 公告日期 | 2026-08-27 | 2026-04-30 | 2026-04-08 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |